How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

551 results for

Narcotic Seeking Behavior

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Narcotic Seeking Behavior

Narcotic Seeking Behavior Narcotic Seeking Behavior Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Narcotic Seeking Behavior Narcotic (...) Seeking Behavior Aka: Narcotic Seeking Behavior , Opioid Seeking Behavior , Aberrant Drug-Related Behavior , Pseudo-addiction , Drug Seeking Behavior , Prescription Drug Abuse , Prescription Drug Diversion , Prescription Drug Misuse , Prescription Drug Monitoring Program From Related Chapters II. Epidemiology Prescription Drug Diversion is common Prescription Drug Abusers get their medications from family or friends in over 70% of cases For every 1 death from prescription abuse Treatment admissions

2018 FP Notebook

2. Narcotics, Benzodiazepines, Stimulants, and Gabapentin: Policies, Initiatives, and Practices Across Canada, 2014

Narcotics, Benzodiazepines, Stimulants, and Gabapentin: Policies, Initiatives, and Practices Across Canada, 2014 Narcotics, Benzodiazepines, Stimulants, and Gabapentin: Policies, Initiatives, and Practices Across Canada, 2014 | CADTH.ca Find the information you need Narcotics, Benzodiazepines, Stimulants, and Gabapentin: Policies, Initiatives, and Practices Across Canada, 2014 Narcotics, Benzodiazepines, Stimulants, and Gabapentin: Policies, Initiatives, and Practices Across Canada, 2014 (...) , as well as place a significant burden on our health, social services, and public safety systems.” 1 The purpose of this Environmental Scan is to provide an overview of policies, practices, and initiatives which the publicly funded drug programs, colleges of physicians and surgeons, and colleges of pharmacy are implementing across Canada to address the misuse, abuse, and diversion of prescription narcotics (opioids), benzodiazepines, stimulants, and gabapentin. This information may assist drug policy

2015 Canadian Agency for Drugs and Technologies in Health - Environmental Scanning

3. Narcotic Seeking Behavior

Narcotic Seeking Behavior Narcotic Seeking Behavior Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Narcotic Seeking Behavior Narcotic (...) Seeking Behavior Aka: Narcotic Seeking Behavior , Opioid Seeking Behavior , Aberrant Drug-Related Behavior , Pseudo-addiction , Drug Seeking Behavior , Prescription Drug Abuse , Prescription Drug Diversion , Prescription Drug Misuse , Prescription Drug Monitoring Program From Related Chapters II. Epidemiology Prescription Drug Diversion is common Prescription Drug Abusers get their medications from family or friends in over 70% of cases For every 1 death from prescription abuse Treatment admissions

2015 FP Notebook

4. Treatment Outcomes Among Patients With Prescription Narcotic Drug Use Disorder

Criteria: Patients seeking treatment for prescription narcotic drug use disorder (ICD-10: F111, F112, F131, and F132) ≥ 18 years Willing to participate and who have provided written informed consent. Exclusion Criteria: Inability to understand spoken and written study information. Having started tapering prior to the start of the study. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff (...) provided by Johan Franck, Karolinska Institutet: behavior, addictive addiction medicine substance-related disorders abuse, narcotic addiction, narcotic analgesics, narcotic opioid-related disorders benzodiazepines prescription drugs Additional relevant MeSH terms: Layout table for MeSH terms Disease Substance-Related Disorders Pathologic Processes Chemically-Induced Disorders Mental Disorders Narcotics Central Nervous System Depressants Physiological Effects of Drugs Analgesics Sensory System Agents

2018 Clinical Trials

5. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review Full Text available with Trip Pro

of heightened vulnerability to experimentation and habitual use of substances ( ). For example, due to neurodevelopmental processes, adolescents are more prone to impulsive behaviors, risk taking, and drug and reward seeking compared to adults—all of which are behaviors that are linked to substance use ( ; ). Indeed, animal studies of neural processing have demonstrated that adolescent and adult brains respond differently to rewards, with activity in adolescents' brain regions of learning and habit (...) formation potentially predisposing them to form problematic substance use habits ( ). This area of research has also demonstrated that adolescents consume larger quantities of alcohol than adults, a behavior that continues into adulthood, suggesting that drinking habits begun early in life, i.e., during adolescence, may worsen relative to habits begun during adulthood and extend for longer periods of time ( ). In addition to neurodevelopmental findings, research has demonstrated that adolescents develop

2018 Campbell Collaboration

6. Recruitment to doping and help-seeking behavior of eight female AAS users Full Text available with Trip Pro

Recruitment to doping and help-seeking behavior of eight female AAS users Doping with anabolic androgenic steroids in sports has now developed to a widespread use of these agents among young people outside the sport. This is of major concern to the society. The purpose of the use is mainly for aesthetic reasons and is seen as a male phenomenon. But use also occurs in women where the knowledge is scarce. Our aim was to identify the pattern of doping agents in eight female cases and compare them (...) with similar data from men.Eight female users were recruited through Anti-Doping Hot-Line, a national telephone counseling service on doping issues during the years 1998-2004. The use was confirmed with urine doping analysis at the Doping Laboratory. The characteristic of use, co-use of narcotics/other doping agents, exercise pattern, adverse-side effects, family history and reason to begin was evaluated.The women used on average 1.9 different anabolic androgenic steroids and clenbuterol preparations

2016 Substance abuse treatment, prevention, and policy

7. Cognitive?Behavioural Therapies for Young People in Outpatient Treatment for Non?Opioid Drug Use: A Systematic Review Full Text available with Trip Pro

is perceived as a complex, multi‐determined, cognitive and behavioural pattern influenced by several domains, including family history, environmental genetic factors, and comorbid psychopathologies that all play a contributing role in the development of and/or perpetuation of drug use ( ). The primary focus of CBT is on reducing users' positive expectations about drug use, enhancing their self‐confidence to resist drugs, and improving their problem‐solving skills and skills for coping with daily life (...) Cognitive?Behavioural Therapies for Young People in Outpatient Treatment for Non?Opioid Drug Use: A Systematic Review Cognitive‐Behavioural Therapies for Young People in Outpatient Treatment for Non‐Opioid Drug Use: A Systematic Review - Filges - 2015 - Campbell Systematic Reviews - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term SYSTEMATIC REVIEW Open Access Cognitive‐Behavioural Therapies

2015 Campbell Collaboration

8. Take-home methadone: contingency effects on drug-seeking and productivity of narcotic addicts. (Abstract)

Take-home methadone: contingency effects on drug-seeking and productivity of narcotic addicts. 735908 1979 03 24 2018 04 18 0306-4603 3 3-4 1978 Addictive behaviors Addict Behav Take-home methadone: contingency effects on drug-seeking and productivity of narcotic addicts. 215-20 Milby J B JB Garrett C C English C C Fritschi O O Clarke C C eng Clinical Trial Journal Article Randomized Controlled Trial England Addict Behav 7603486 0306-4603 0 Pharmaceutical Preparations UC6VBE7V1Z Methadone IM (...) Adult Behavior Efficiency Female Humans Male Methadone administration & dosage therapeutic use Middle Aged Pharmaceutical Preparations urine Self Administration Substance-Related Disorders psychology rehabilitation 1978 1 1 1978 1 1 0 1 1978 1 1 0 0 ppublish 735908 0306-4603(78)90022-9

1979 Addictive behaviors Controlled trial quality: uncertain

9. Narcotic Use and Postoperative Doctor Shopping Among Patients with Nephrolithiasis Requiring Operative Intervention: Implications for Patient Safety. (Abstract)

institution from January to December 2013. Using the Tennessee CSMD (Controlled Substances Medication Database) patients were categorized by the number of postoperative narcotic providers. Doctor shopping behavior was identified as any patient seeking more than 1 narcotic provider within 3 months of surgery. Demographic and clinical characteristics associated with doctor shopping behavior were identified.During the study period 200 eligible patients underwent ureteroscopy with laser lithotripsy (...) Narcotic Use and Postoperative Doctor Shopping Among Patients with Nephrolithiasis Requiring Operative Intervention: Implications for Patient Safety. We sought to determine perioperative patterns of narcotic use and the prevalence of postoperative doctor shopping among patients with nephrolithiasis requiring operative management.We retrospectively reviewed the records of consecutive patients residing in Tennessee who required ureteroscopy with laser lithotripsy for nephrolithiasis at a single

2016 Journal of Urology

10. Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects

Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Studies (...) of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects (YHO) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01536925 Recruitment Status : Completed First Posted : February 22, 2012 Last Update Posted : April 5, 2018 Sponsor: Wayne State University Collaborator: National Institute on Drug Abuse

2012 Clinical Trials

11. The Effectiveness of Incarceration?Based Drug Treatment on Criminal Behavior: A Systematic Review Full Text available with Trip Pro

The Effectiveness of Incarceration?Based Drug Treatment on Criminal Behavior: A Systematic Review The Effectiveness of Incarceration‐Based Drug Treatment on Criminal Behavior: A Systematic Review - Mitchell - 2012 - Campbell Systematic Reviews - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term UPDATED SYSTEMATIC REVIEW Open Access The Effectiveness of Incarceration‐Based Drug Treatment on Criminal (...) Behavior: A Systematic Review Corresponding Author E-mail address: Corresponding author Ojmarrh Mitchell, Ph.D. Associate Professor Department of Criminology 4202 E. Fowler Ave. SOC107 University of South Florida Tampa, FL 33620 E‐mail: Corresponding Author E-mail address: Corresponding author Ojmarrh Mitchell, Ph.D. Associate Professor Department of Criminology 4202 E. Fowler Ave. SOC107 University of South Florida Tampa, FL 33620 E‐mail: First published: 01 November 2012 Citations: Linked article

2012 Campbell Collaboration

12. Neural Basis of Eating Behavior in Abstinent Smokers

quit attempt in the next 1-2 months (treatment-seeking), because our prior work suggests that motivated subjects are more sensitive to medication effects on smoking behavior. Using a scale from 0 to 100 (100, being extremely interested), subjects must rate their interest in quitting smoking within the next 1-2 months greater than 50. Able to communicate fluently in English (i.e. speaking, writing, and reading). Exclusion Criteria Subjects who present and/or self-report with the following criteria (...) Neural Basis of Eating Behavior in Abstinent Smokers Neural Basis of Eating Behavior in Abstinent Smokers - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Neural Basis of Eating Behavior in Abstinent Smokers

2018 Clinical Trials

13. Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction

Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum (...) number of saved studies (100). Please remove one or more studies before adding more. Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02801357 Recruitment Status : Completed First

2016 Clinical Trials

14. Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder

in this summary. Participants who experienced suicidal ideation and suicidal behavior are only summarized in the suicidal behavior since behavior is more severe than ideation. C-SSRS baseline version was completed during the screening visit. C-SSRS 'since-last-visit' version was completed weekly for the first month and at least every month until the end of the study. Shift table category titles are structured as: baseline category/treatment category. The category 'No Suicidal Ideation or Behaviour' has been (...) Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2015 Clinical Trials

15. Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine

Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02357901 Recruitment Status : Completed First Posted

2015 Clinical Trials

16. Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers

Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Ghrelin for Alcohol Use in Non (...) -Treatment-Seeking Heavy Drinkers The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01779024 Recruitment Status : Completed First Posted : January 29, 2013 Results First Posted : August 3, 2018 Last Update Posted : August 3, 2018 Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA

2013 Clinical Trials

17. Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine, THC and alcohol Full Text available with Trip Pro

Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine, THC and alcohol Unified theories of addiction are challenged by differing drug-seeking behaviors and neurobiological adaptations across drug classes, particularly for narcotics and psychostimulants. We previously showed that protracted abstinence to opiates leads to despair behavior and social withdrawal in mice, and we identified a transcriptional signature in the extended (...) amygdala that was also present in animals abstinent from nicotine, Δ9-tetrahydrocannabinol (THC) and alcohol. Here we examined whether protracted abstinence to these four drugs would also share common behavioral features, and eventually differ from abstinence to the prototypic psychostimulant cocaine. We found similar reduced social recognition, increased motor stereotypies and increased anxiety with relevant c-fos response alterations in morphine, nicotine, THC and alcohol abstinent mice. Protracted

2016 Addiction biology

18. Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain

smoking and gain less weight. Condition or disease Intervention/treatment Phase Smoking Cessation Weight Loss Behavioral: BAS+ Behavioral: SC Not Applicable Detailed Description: This is a randomized clinical trial of the efficacy of a behavioral activation intervention to smoking cessation and to post-cessation weight gain (BAS+) plus transdermal nicotine (TN) compared to standard smoking cessation counseling (SC) plus TN in treatment-seeking smokers. After completing an Intake Visit (~week -3 (...) Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2016 Clinical Trials

19. Quantifying Drug-seeking Behavior: A Case Control Study. (Abstract)

pain.The odds ratios for each studied behavior being used by drug seeking patients as compared to controls were: non-narcotic allergy: 3.4, medication by name: 26.3, medication refill: 19.2, lost or stolen medication: 14.1, three or more pain related visits in different parts of the body: 29.3, 10 out of 10 pain: 13.9, three visits in 7 days: 30.8, out of medication: 26.9, headache: 10.9, back pain: 13.6, and dental pain: 6.3. Zero patients in the control group complained of greater than 10-out-of-10 (...) Quantifying Drug-seeking Behavior: A Case Control Study. Drug-seeking behavior (DSB) is common in the Emergency Department (ED), yet the literature describing DSB in the ED consists predominantly of anecdotal evidence.To perform a case-control study examining the relative frequency of DSB in suspected drug-seeking patients as compared to all ED patients.We performed a retrospective chart review of 152 drug-seeking patients and of age- and gender-matched controls, noting which of the following

2011 Journal of Emergency Medicine

20. To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers

and Statistical Manual of Mental Disorders (DSM-IV) alcohol or substance dependence or abuse, including treatment-seeking behaviour, as determined by the Investigator or Mini-international neuropsychiatric interview (MINI). Self administered Beck Depression Inventory II scale total score greater than 13 or suicide question score greater than zero at screening. Current or past chronic history of neurological disorders. Current or past history of Axis 1 psychiatric disorders including eating disorders (...) such as anorexia nervosa, bulimia nervosa and binge eating disorder, including treatment seeking behaviour using the MINI. Subject who, in the investigator/designee's judgement, poses a significant suicide risk. Evidence of serious suicide risk may include any history of suicidal behaviour and/or any evidence of suicidal ideation on any questionnaires e.g. type 4 or 5 on the C-SSRS in the last 5 years. Concomitant drug use: Positive urine screen for amphetamines, barbiturates, cocaine, opiates, cannabinoids

2012 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>